North Tide Capital’s Gilead Sciences GILD Stock Holding History

North Tide Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$40.5M	Sell	500,000 -500,000	-50%	-$38.2M	8.64%	5
2017 Q2	$70.8M	Hold	1,000,000	–	–	15.75%	3
2017 Q1	$67.9M	Buy	1,000,000 +500,000	+100%	+$35.2M	10.44%	4
2016 Q4	$35.8M	Sell	500,000 -300,000	-38%	-$22.3M	6.12%	4
2016 Q3	$63.3M	Buy	+800,000	New	+$65M	6.89%	6
2015 Q3	–	Sell	-500,000	Closed	-$58.5M	–	19
2015 Q2	$58.5M	Buy	+500,000	New	+$54.6M	4.23%	8

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

North Tide Capital's GILD Position: Q3 2017 in Review

North Tide Capital reduced its Gilead Sciences (GILD) stake by 50% in Q3 2017, selling an estimated $38.2M and leaving 500,000 shares worth $40.5M. The position accounts for 8.64% of the portfolio, ranked #5.

North Tide Capital first reported a position in GILD in Q2 2015 and has held it in 6 quarters since. The position peaked at $70.8M in Q2 2017. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

North Tide Capital held 500,000 shares of Gilead Sciences worth $40.5M as of Q3 2017.
North Tide Capital sold 500,000 Gilead Sciences shares in Q3 2017, an estimated $38.2M.
Gilead Sciences made up 8.64% of North Tide Capital's portfolio in Q3 2017, its #5 holding.
North Tide Capital first reported a position in Gilead Sciences in Q2 2015 and has held it in 6 quarters since.
North Tide Capital's Gilead Sciences position peaked at $70.8M in Q2 2017.
1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on North Tide Capital's 13F filing for Q3 2017, filed 14 Nov 2017.